for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Hangzhou Tian-Mu-Shan Pharm. Enterp. Co

600671.SS

Latest Trade

15.34CNY

Change

0.48(+3.23%)

Volume

6,366,202

Today's Range

14.70

 - 

15.35

52 Week Range

11.40

 - 

27.92

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
14.86
Open
14.90
Volume
6,366,202
3M AVG Volume
185.25
Today's High
15.35
Today's Low
14.70
52 Week High
27.92
52 Week Low
11.40
Shares Out (MIL)
121.78
Market Cap (MIL)
1,868.09
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Hangzhou Tianmushan Pharmaceutical's Board Appoints New General Manager

Hangzhou Tianmushan Pharmaceutical Elects Chairman, Appoints General Manager

Hangzhou TianMuShan Pharmaceutical Enterprise sees FY 2017 net profit up 568.88 pct

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Hangzhou Tian-Mu-Shan Pharm. Enterp. Co

Hangzhou TianMuShan Pharmaceutical Enterprise Co., Ltd is a China based company principally engaged in the research and development, production and sales of pharmaceuticals and related health products. The Company is mainly engaged in the manufacture of chemical drug substances, processing of Chinese herbal pieces as well as the manufacture of traditional Chinese medicine preparation and Western medicine. The Company's main products are bright eye drops, FufangXianzhuliYe, amoxicillin and clavulanate potassium tablets, Hechedazao Jiaonang, Liu Wei Di Huang oral liquid, menthol, and peppermint oil. The Company mainly operates its business in the domestic market.

Industry

Biotechnology & Drugs

Contact Info

Building 3

Xixile Valley, No.738, Wener West Road

+86.571.63722229

http://www.hztmyy.com

Executive Leadership

Yulin Li

Vice Chairman of the Board

Yining Xu

Vice Chairman of the Board

Chengquan Yang

Vice Chairman of the Board

Yamin Zhou

Chief Financial Officer

Zuyue Li

General Manager

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
6.58
Price To Book (MRQ)
30.49
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
150.27
LT Debt To Equity (MRQ)
53.86
Return on Investment (TTM)
-20.71
Return on Equity (TTM)
-10.35

Latest News

BRIEF-Hangzhou Tianmushan Pharmaceutical Enterprise receives GMP certificate

Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd :

BRIEF-Hangzhou Tianmushan Pharmaceutical Scraps Asset Restructuring Plan

Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd:

BRIEF-Hangzhou Tianmushan Pharmaceutical Enterprise receives GMP certificate

Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd :

BRIEF-Hangzhou Tianmushan Pharmaceutical Enterprise unit receives GMP certificate

Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd :

REFILE-BRIEF-Hangzhou Tianmushan Pharma to acquire Jilin-based pharma firm

Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up